Cargando…
Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma
BACKGROUND: Treatment personalization via tumor molecular testing holds promise for improving outcomes for patients with pediatric low-grade glioma (PLGG). We evaluate the health economic impact of employing tumor molecular testing to guide treatment for patients diagnosed with PLGG, particularly th...
Autores principales: | Rios, Juan David, Velummailum, Russanthy, Bennett, Julie, Nobre, Liana, Tsang, Derek S., Bouffet, Eric, Hawkins, Cynthia, Tabori, Uri, Denburg, Avram, Pechlivanoglou, Petros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722113/ https://www.ncbi.nlm.nih.gov/pubmed/34980048 http://dx.doi.org/10.1186/s12887-021-03069-1 |
Ejemplares similares
-
LGG-12. CLINICAL AND MOLECULAR FEATURES OF DISSEMINATED PEDIATRIC LOW-GRADE GLIOMA
por: Levine, Adrian, et al.
Publicado: (2023) -
ACQUIRED PTEN LOSS MAY MEDIATE DABRAFENIB AND TRAMETINIB RESISTANCE IN BRAF V600E–MUTATED EPITHELIOID GLIOBLASTOMA: A CASE REPORT
por: Ahmed, Abrar, et al.
Publicado: (2023) -
IMMU-08. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEFICIENT (RRD) HIGH-GRADE GLIOMA FAILING ANTI-PD1 MONOTHERAPY: AN IRRDC REPORT
por: Das, Anirban, et al.
Publicado: (2023) -
Pakistan National Guidelines for Pediatric High-Grade Gliomas
por: Bashir, Farrah, et al.
Publicado: (2023) -
LGG-19. SPINAL LOW-GRADE GLIOMAS IN CANADIAN CHILDREN: A MULTI-CENTRE RETROSPECTIVE REVIEW
por: Coltin, Hallie, et al.
Publicado: (2020)